Cancer sequencing & genomics services
MR DNA supports cancer research with next-generation sequencing across targeted panels, whole exome, whole genome, transcriptome, and custom oncology workflows.
How we support cancer genomics
Advances in next-generation sequencing have transformed cancer research by enabling comprehensive analysis of somatic mutations, gene expression changes, and structural variation. MR DNA provides access to industry-standard platforms and continually updated assay options.
Targeted cancer panels
Focused sequencing of cancer-relevant genes using Illumina and Thermo Fisher panels.
Whole exome sequencing
Comprehensive coding-region analysis for mutation discovery and cohort studies.
Whole genome sequencing
Genome-wide variant detection including structural variants and noncoding regions.
RNA sequencing
Transcriptome and fusion analysis to characterize gene expression and pathway activity.
Cell-free DNA (cfDNA)
Liquid biopsy and circulating tumor DNA workflows (project dependent).
Custom oncology assays
Bring your panel or work with us to design a targeted sequencing strategy.
Platforms & data delivery
- Illumina NovaSeq, HiSeq, MiSeq
- PacBio long-read sequencing (project dependent)
- Raw FASTQ files with QC metrics
- Optional variant calling, annotation, and reporting
What to include in a quote request
- Sample type and number
- Preferred assay (panel, exome, genome, RNA)
- Tumor / normal pairing (if applicable)
- Desired analysis level
Advance your cancer research
Contact our team to discuss your oncology project and sequencing requirements.